A shared facility can no longer rest its cross-contamination case on "10 ppm" or "1/1000 of a dose" alone. The starting number is a PDE.
PDE stands for permitted daily exposure. The EMA guideline on health-based exposure limits defines it as a substance-specific dose that is unlikely to cause an adverse effect if an individual is exposed at or below it every day for a lifetime. It is derived for each active substance from pharmacological and toxicological data.
EU GMP Chapters 3 and 5 have pointed to this toxicological evaluation since 2015, and the EMA's questions and answers say health-based exposure limits should be established for all medicinal products.
Two things hang on the number. One is the cleaning limit: the 2015 text of Annex 15 says carryover limits should be based on a toxicological evaluation. In the Q&A, historically used cleaning limits should be retained, and can serve as alert limits where they give enough assurance that the health-based limit will not be exceeded.
The other is the building. The list of technical measures in the 2015 text of Chapter 5 includes air-locks and pressure cascades, minimizing the risk from recirculated air, closed systems, separate HVAC systems and dedicated facilities. The lower the PDE, the more of that list the design needs.
So ask for the PDE of each product at URS stage, while the return air question is still open.
Industries




